ProfileGDS4718 / 206802_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 57% 62% 57% 63% 62% 58% 58% 63% 60% 61% 59% 59% 59% 58% 58% 57% 60% 56% 59% 57% 60% 60% 56% 59% 59% 59% 61% 58% 60% 61% 59% 56% 61% 58% 60% 57% 59% 61% 63% 56% 60% 61% 57% 55% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.9572157
GSM549102patient 115, normal, homogenized [OPG study]6.2636662
GSM549104patient 119, normal, homogenized [OPG study]5.9603457
GSM549108patient 138, normal, homogenized [OPG study]6.3654163
GSM549119patient 077, normal, homogenized [OPG study]6.2701862
GSM549133patient 032, cancer, homogenized [OPG study]5.9380258
GSM549139patient 042, cancer, homogenized [OPG study]6.0036458
GSM549099patient 107, normal, homogenized [OPG study]6.2963363
GSM549109patient 139, normal, homogenized [OPG study]6.1657860
GSM549110patient 046, normal, homogenized [OPG study]6.1764561
GSM549114patient 063, normal, homogenized [OPG study]6.039759
GSM549122patient 082, normal, homogenized [OPG study]6.1040459
GSM549134patient 033, cancer, homogenized [OPG study]6.0405659
GSM549136patient 036, cancer, homogenized [OPG study]5.9788458
GSM549140patient 044, cancer, homogenized [OPG study]5.9635758
GSM549111patient 047, normal, homogenized [OPG study]5.9264557
GSM549113patient 057, normal, homogenized [OPG study]6.1150960
GSM549132patient 031, cancer, homogenized [OPG study]5.8499256
GSM549137patient 038, cancer, homogenized [OPG study]6.0572659
GSM549142patient 047, cancer, homogenized [OPG study]6.0162757
GSM549100patient 110, normal, homogenized [OPG study]6.1349160
GSM549107patient 135, normal, homogenized [OPG study]6.0654860
GSM549115patient 068, normal, homogenized [OPG study]5.854956
GSM549116patient 072, normal, homogenized [OPG study]6.0394559
GSM549120patient 078, normal, homogenized [OPG study]6.0646759
GSM549131patient 030, cancer, homogenized [OPG study]6.0598659
GSM549118patient 074, normal, homogenized [OPG study]6.2139961
GSM549129patient 027, cancer, homogenized [OPG study]6.0250858
GSM549123patient 088, normal, homogenized [OPG study]6.1239860
GSM549124patient 006, cancer, homogenized [OPG study]6.177461
GSM549126patient 015, cancer, homogenized [OPG study]6.0273759
GSM549128patient 025, cancer, homogenized [OPG study]5.890556
GSM549103patient 117, normal, homogenized [OPG study]6.2291361
GSM549117patient 073, normal, homogenized [OPG study]5.9283558
GSM549138patient 041, cancer, homogenized [OPG study]6.1331460
GSM549141patient 045, cancer, homogenized [OPG study]5.9389457
GSM549130patient 028, cancer, homogenized [OPG study]6.056559
GSM549101patient 111, normal, homogenized [OPG study]6.242561
GSM549105patient 128, normal, homogenized [OPG study]6.3057663
GSM549106patient 134, normal, homogenized [OPG study]5.8337556
GSM549112patient 048, normal, homogenized [OPG study]6.1050860
GSM549125patient 011, cancer, homogenized [OPG study]6.195361
GSM549127patient 024, cancer, homogenized [OPG study]5.9510357
GSM549135patient 035, cancer, homogenized [OPG study]5.8102655